Table 2 Laboratory parameters of the studied cohort

 Protein (mg/dL)

1 ± 0.6

1.2 ± 0.7

0.9 ± 0.4

0.024

 WBCs (cell/mm³)

656.2 ± 1488.6

1663.3 ± 2167.3

108.1 ± 60.7

< 0.001

 PMNLs (cell/mm³)

524.5 ± 1346.9

1402.5 ± 1993.3

46.7 ± 38.3

< 0.001

 WBCs (× 10³/μL)

10.4 ± 5.9

13.7 ± 7.2

8.5 ± 4.2

< 0.001

 Neutrophils (× 10³/μL)

7.9 ± 5.3

11.3 ± 6.5

6.1 ± 3.3

< 0.001

 Lymphocytes (× 10³/μL)

1.6 ± 1.1

1.3 ± 0.7

1.7 ± 1.2

0.001

 Neutrophil/lymphocyte ratio

6 ± 4.1

9.6 ± 4.4

4 ± 1.9

< 0.001

 Platelets (× 10³/μL)

143.1 ± 89.3

160.3 ± 109.7

133.7 ± 74.5

0.071

 MPV (fL)

9 ± 1.7

9.7 ± 1.8

8.6 ± 1.5

< 0.001

 ALT(U/L)

63.5 ± 131

80.9 ± 181.1

54.0 ± 92.3

0.01

 AST(U/L)

107.9 ± 157.6

133.3 ± 208.8

94.0 ± 119.4

0.098

 Total bilirubin (mg/dL)

5.3 ± 6.2

5.7 ± 6.6

5 ± 6

0.32

 Serum albumin (g/dL)

2.3 ± 0.5

2.2 ± 0.5

2.3 ± 0.5

0.353

 INR

1.6 ± 0.5

1.6 ± 0.5

1.6 ± 0.4

0.447

 Creatinine (mg/dL)

1.6 ± 0.9

1.7 ± 1

1.6 ± 0.9

0.162

 Serum Na (mmol/l)

130.2 ± 7.7

129.8 ± 8.2

130.4 ± 7.4

0.48